No abstract available
MeSH terms
-
Agranulocytosis / chemically induced
-
Agranulocytosis / physiopathology*
-
Antifungal Agents / pharmacology*
-
Antifungal Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cytarabine / administration & dosage
-
Daunorubicin / administration & dosage
-
Depression, Chemical
-
Hematopoiesis / drug effects*
-
Humans
-
Leukemia, Myeloid, Acute / complications
-
Leukemia, Myeloid, Acute / drug therapy
-
Leukemia, Myelomonocytic, Acute / complications
-
Leukemia, Myelomonocytic, Acute / drug therapy
-
Life Tables
-
Mitoxantrone / administration & dosage
-
Mycoses / drug therapy*
-
Mycoses / etiology
-
Thioguanine / administration & dosage
-
Thrombocytopenia / chemically induced
-
Thrombocytopenia / physiopathology*
Substances
-
Antifungal Agents
-
Cytarabine
-
Mitoxantrone
-
Thioguanine
-
Daunorubicin
Supplementary concepts
-
DAT protocol 1
-
NOAC protocol